Course Information

15th Annual UCLA Liver Diseases Symposium

Live In-Person & Live Virtual Learning
Four Seasons Hotel Westlake Village
Westlake Village, California

October 15, 2022

Download: [ PDF ]

The 15th Annual UCLA Liver Diseases Virtual Symposium will provide a state-of-the-art update and scientific exchange on prevalent liver diseases and their complications using a multi-disciplinary approach with hepatologists, radiologists and surgeons.

The 15th Annual UCLA Liver Diseases Symposium will also be available through a live virtual meeting web platform.

  • Attendees who choose to attend the live virtual activity will receive a virtual meeting link and password to access the live virtual conference.
  • All registrants (live or virtual) will be provided the opportunity to review recorded sessions up to 3 weeks following the conference.
  • Attendees will be awarded CME credit commensurate with the extent of their participation in the live activity (either in-person or virtual). The recorded sessions are not certified for CME credit.

In the event in-person attendance is cancelled or capacity limits modified per CDC or public health guidelines, the UCLA Liver Diseases conference will be modified accordingly or presented entirely as a live virtual activity.


*Note: To ensure course material is received before the course begins, early registration is advised. Online registration will close at 11:59 PM on Sunday, October 9th.

Enrollment after online registration has closed:

  • Live Virtual registration will be accepted via phone until 5:00 PM on Friday, October 14th and between 6:30 am – 10:00 am on Saturday, October 15th. Please call (310) 794-2620 to register for the virtual program.

Course Fees

  • $50 - Physicians (Live In-Person and Live Virtual)
  • $35 - Nurses and Other Allied Healthcare Professionals (Live In-Person and Live Virtual)
  • $25 - Fellows and Residents (Live In-Person and Live Virtual)

Enroll Online

To enroll, click here.

Enroll By Fax

Fax with credit card and expiration date directly to our office at (310) 794-2624

Enroll By Mail

Complete and return the registration form to the following address:
Office of Continuing Medical Education
David Geffen School of Medicine at UCLA
15th Annual UCLA Liver Diseases Symposium
10920 Wilshire Blvd., Suite 1060
Los Angeles, CA 90024-6512.


Due to the low enrollment fee, no refunds will be offered. A full refund will be provided if this course is cancelled, or postponed.


Professor of Medicine and Surgery
Medical Director, Pfleger Liver Institute
Medical Director, Adult Liver Transplant Program
Chief, Transplant Hepatology
Head, Outcomes Research in Hepatology
Adjunct Professor of Nursing


Fady Kaldas, MD, FACS
Kelly Lee Tarantello Chair in Integrative Liver Transplantation
Associate Professor of Surgery
Director, Multi-Organ Transplantation Fellowship Program
Director, Liver Transplant Service
Co-Director, Heart – Liver Disease Program

Course Faculty

Vatche Agopian, MD
Associate Professor of Surgery
Associate Director, General Surgery Residency Program
Director, Dumont-UCLA Liver Cancer Center

Gina Choi, MD
Assistant Professor of Medicine and Surgery
Associate Director, Transplant Hepatology Fellowship Program

Mohamed El Kabany, MD
Associate Professor of Medicine

Douglas G. Farmer, MD, FACS
Professor of Surgery
Director, Intestinal Transplant Program
Director, Pediatric Liver Transplant Program
Interim Chief, Division of Liver and Pancreas Transplantation

Steven-Huy B. Han, MD, AGAF, FAASLD
Philip L. Palumbo Chair in Clinical Hepatology
Professor of Medicine and Surgery
Program Director, Transplant Hepatology Fellowship

Saeed Sadeghi, MD
Professor of Medicine
Division of Hematology & Oncology

Jessica Stewart, MD
Assistant Professor of International Radiology

Akshay Shetty, MD
Assistant Professor of Medicine

Beshoy T. Yanny, MD
Assistant Professor of Medicine
Program Leader, Hepatology
UCLA Medical Center, Santa Monica

Saturday, October 15, 2022

7:45 am Breakfast & Registration
8:30 am Welcome & Introduction
Mohamed El Kabany, MD
8:35 am “B, C, and D” of Viral Hepatitis Soup
Sammy Saab, MD, MPH
9:00 am Indications for Liver Transplantation & When to Refer for OLT
Fady Kaldas, MD
9:25 am Role of TIPS in the Management of Cirrhosis Portal Hypertension
Jessica Stewart, MD
9:50 am Update on Biomarkers for Liver Cancer Screening
Vatche Agopian, MD
10:15 am Break
10:30 am Advances in the Treatment of Hepatocellular Carcinoma
Saeed Sadeghi, MD
10:55 am Current and Future Therapy of NASH
 Akshay Shetty, MD
11:20 am Long Term Management of Liver Transplant Recipients
Gina Choi, MD
11:45 am Debate: Role of Liver Transplantation in Patients with Alcoholic Hepatitis
Debaters: Douglas Farmer, MD and Beshoy Yanny, MD
Moderator: Steven-Huy Han, MD
12:15 pm Panel Discussion: Question and Answer
Moderator: Sammy Saab, MD, MPH
12:25 pm Closing Remarks
Douglas Farmer, MD
12:30 pm Adjourn
Douglas Farmer, MD

At the completion of this program, participants will be able to:

  • Identify liver failure milestones in patients with cirrhosis and understand the role of liver transplantation.
  • Review the pros and cons of Transjugular Intrahepatic Portosystemic Shunts in patients with cirrhosis and portal hypertension.
  • Discuss updates in the management of patients with viral hepatitis B, C, and D.
  • Implement new and novel strategies for the treatment of hepatocellular carcinoma. 
  • Review the treatment of alcoholic hepatitis and understand controversies associated with early liver transplantation.
  • Treat non-alcoholic fatty liver disease and employ non-invasive tests for diagnosis.


The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

The California State Board of Registered Nursing accepts courses approved by the AMA for category 1 credit as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.

The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.


Four Seasons Hotel Westlake Village
Two Dole Drive
Westlake Village, CA 91362
(818) 575-3000

Conference Location

Sound Stage Room


Valet parking: $13